In this section of the General Tradeshow News Site, you'll find event-related news releases from PR Newswire. The releases are listed in chronological order and are archived by month and year.
Epson Experts to Offer Live Virtual Demos and Present Actionable Insights Around Core Factory Automation Requirements to Help Customers Maximize Potential for Project Success
- ILUMYA is the first IL-23 inhibitor to complete five years of study based on a pooled analysis of two Phase 3 efficacy and safety extension trials in moderate-to-severe plaque psoriasis[1]
Dr. Chad E. Beyer will present psychometric findings from the first-ever, multi-center trial conducted in patients with trichotillomania - an impulse control disorder marked by repetitive hairpulling behaviors
NexTech AR invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com